Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

With the bio/pharmaceutical industry facing patent expirations in the near-term for key drugs, bio/pharma companies are facing the pressure of staying competitive in a bio/pharmaceutical landscape where the therapies are growing increasingly complex amid a major shift toward personalized medicines. Pharmaceutical Technology® spoke with Informa Markets about the critical role outsourcing plays in today’s competitive environment as well as into the future.

Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.

About the author

Outsourcing Innovation eBook February 2024

Read the article: Pharmaceutical Outsourcing Present and Future

Read the eBook: Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook February 2024

Chris Spivey is the editorial director of Pharmaceutical Technology® and Pharmaceutical Technology Europe®.

Article details

Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 31-32

Citation

When referring to this article, please cite it as Spivey, C. Pharmaceutical Outsourcing Present and Future. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.

Articles in this issue

over 1 year ago

Article

Managing the Complexity of Modern Sterile Product Developments

over 1 year ago

Article

Navigating the Preclinical CRO Outsourcing Process

over 1 year ago

Article

A Closer Look at Affinity Ligands

over 1 year ago

Article

Ensuring Quality in Contracted Support

over 1 year ago

Article

How to Evaluate a CDMO’s Commitment to Quality

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!